Evgeny Izumchenko to Cetuximab
This is a "connection" page, showing publications Evgeny Izumchenko has written about Cetuximab.
Connection Strength
0.073
-
Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance. Genome Med. 2018 05 23; 10(1):37.
Score: 0.038
-
SMAD4 Loss Is Associated with Cetuximab Resistance and Induction of MAPK/JNK Activation in Head and Neck Cancer Cells. Clin Cancer Res. 2017 Sep 01; 23(17):5162-5175.
Score: 0.035